XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration agreements - Janssen Biotech (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2022
USD ($)
target
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Collaboration agreements          
Collaboration revenue   $ 5,573,000 $ 11,000 $ 11,893,000 $ 32,000
Janssen Agreement          
Collaboration agreements          
Number of targets designated | target 3        
Proceeds from collaborators $ 40,000,000        
Collaboration revenue   4,900,000   10,900,000  
Deferred revenue   29,100,000   29,100,000  
Remaining performance obligation   29,100,000   29,100,000  
Contract assets   $ 0   $ 0  
Development, Regulatory & Commercial | Janssen Agreement          
Collaboration agreements          
Collaboration arrangements, maximum aggregate milestones 505,000,000        
Commercial | Janssen Agreement          
Collaboration agreements          
Collaboration arrangements, maximum aggregate milestones $ 530,000,000